← Back to all trials
Completed
NCT03927820
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
Conditions: COPD, Asthma
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 914
Sponsor: Vanderbilt University Medical Center
Location: Vanderbilt Univeristy Medical Center Nashville Tennessee
Summary
The goal of this study is to assess the impact of pharmacist-led benefits investigations and application of clinical practice guidelines on patient access to inhalers and time to hospital readmission or Emergency Department (ED) visit.
Eligibility Criteria
Inclusion Criteria:
* Adult patient admitted to Vanderbilt University Medical Center (VUMC) (excluding surgery services)
* on a long acting inhaler or prescribed a long acting inhaler during admission.
Exclusion Criteria:
* Diagnosis of cystic fibrosis
* Diagnosis of graft versus host disease (GVHD)
* no medication insurance
* discharge to any post-acute care facility or inpatient hospice
* death during hospitalization
Source: ClinicalTrials.gov (NCT03927820). StuddyBuddy aggregates publicly available trial information.
